Bright future for pharmaceutical industry in Iran!
Bright future for pharmaceutical industry in Iran! By Nahaleh Naraqi The future of the pharmaceutical industry in Iran is bright. Although Iran’s economy is going through difficult years, this industry has managed to pass the year 2023 with better conditions in many indicators. Obstacles and economic fluctuations and infrastructural problems that exist especially in […]
Message from Ms. Nahaleh Naraghi on the occasion of Health Week
Message from Ms. Nahaleh Naraghi on the occasion of Health Week “National Health Week”, a reminder of a serious social responsibility From the 21st till 27th of April is celebrated as “National Health Week” in Iran. The slogan of this year’s national health week is “family health and popularization of health”. “National Health Week” serves […]
Actero’s presence at the 5th Annual Congress of Urinary Tract Cancers
The annual multidisciplinary Uro-oncology Congress was held on 06-08 September 1402 by the Genitourinary Tract Cancer Research Center. In this national congress, about 600 specialists from the fields of urology, pathology, radio-oncology and medical oncology were presented and exchanged information and experiences in this field. also veterans and active philanthropists in the field of genitourinary […]
Production of two new blood pressure medicines in the country
Specialists at a pharmaceutical company have developed two new drugs to treat high blood pressure, a condition that affects approximately 32 million Iranians to varying degrees. The CEO of Actoverco pharmaceutical group, Reza Karimi Mostofi, reported that the specialists of his group have successfully provided the blood pressure medication Telmic-H to patients in Iran. Telmic-H […]
Merck, Actover’s reliable partner in the transfer of the most advanced pharmaceutical technologies to Iran
Merck, a German company, is one of the oldest manufacturers of drugs, chemicals, and health materials globally, and it is a leading name in the research and development (R&D) field in these sectors. The company exports its products to over 60 countries worldwide and is renowned for its innovative technology in the pharmaceutical industry. Merck’s […]
EHA 2023 Actero Sponsorship
Actero company sponsored hematology oncology specialists in European Hematology Association, Being one of the most important event in the field of hematology in order to have more access to the latest scientific update.
Xalico
How to use Xalico: Administer Xalico in combination with fluorouracil and leucovorin every 2 weeks. For adjuvant treatment, continue treatment for up to 12 cycles or unacceptable toxicity. For advanced colorectal cancer, continue treatment until disease progression or unacceptable toxicity. Day 1 Administer Xalico 85 mg/m2 as an intravenous infusion over 120 minutes and leucovorin […]
Evacim
How to use Evacim: Administer only as an intravenous (IV) infusion. Do not administer as an intravenous push or bolus. Do not initiate Evacim until at least 28 days following major surgery. Administer Evacim after the surgical incision has fully healed. First infusion: Administer infusion over 90 minutes. ·Subsequent infusions: Administer second infusion over 60 […]
Lipaxol
How to use Lipaxol : Recommended Dosage for Metastatic Breast Cancer After failure of combination chemotherapy for metastatic breast cancer or relapse within 6 months of adjuvant chemotherapy, the recommended regimen for Lipaxol is 260 mg/m2 administered intravenously over 30 minutes every 3 weeks. for Non-Small Cell Lung Cancer The recommended dose of Lipaxol is […]
Onkotaxel
How to use Onkotaxel: Onkotaxel is a cytotoxic anticancer drug and, as with other potentially toxic compounds, caution should be exercised when handling and preparing Onkotaxel solutions. The use of gloves is recommended. If Onkotaxel initial diluted solution, or final dilution for infusion should come into contact with the skin, immediately and thoroughly wash with […]